Prevalence and control of hypertension among diabetes patients in hospital universiti sains malaysia, malaysia

Salwa Selim Ibrahim, Ayman Selim I. Bougalambou, Fita Rahmawati, Mohamed Azmi Hassali, Syed Azhar Syed Sulaiman


Hypertension  in  patients  with  type  2  diabetes  mellitus  is  a  prevalent condition that leads to substantial morbidity and mortality. The aim of the study was  to  determine  the  prevalence  of  hypertension  in  type  2  diabetes  attending endocrinology  clinics  at  Hospital  Universiti  Sains  Malaysia  (HUSM),  to  describe antihypertensive  treatment  patterns,  and  to  evaluate  the  target  of  blood pressure  achieved  by  antihypertensive  agents.  The  study  was  a  prospective follow-up  descriptive  study.  Study  conducted  at  diabetic  clinic  outpatient  at HUSM,  Kelantan,  Malaysia  from  January  to  December  2007.  A  total  of  1077 diabetic patients involve in this study. The findings of our study showed that the majority patients type 2 diabetes mellitus 998 (92.7 %) had hypertension. For the  patients  who  were  on  antihypertensive  medications,  254  (23.6  %)  of  them were  on  monotherapy  and  311  (28.9  %),  179  (16.6  %), and  198  (18.4  %) respectively  received  two,  three  and  more  than  three  antihypertensive  agents. The majority of patients 872 (87.4 %) were on angiotensin converting enzyme inhibitors/angiotensin receptor blockers either alone or in combination with other antihypertensive  drugs.   A  number  of  601  (55.8  %)  patients  achieved  blood pressure  targets  ≤  130/80  mm  Hg.   Almost  all  patients  with  hypertension  and

diabetes will require a combination of antihypertensive medications. A number of patients was not achieved blood pressure goals ≤ 130/80 mm Hg. There is still need  to  educate  both  patients  and  health  care  providers  of  importance  of achieving target of blood pressure in order to reduce morbidity and mortality in diabetes mellitus patients.

Key words: Hypertension, type 2 diabetes mellitus, hypertension treatment

Full Text:

PDF 121-128


ALLHAT Collaborative Research Group, 2002, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, ,288, 2981–2997.

American Diabetes Association, 2002, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 25, 213

Amos, A. F., McCarty, D. J., and Zimmet, P., 1997, The rising global burden of diabetes and its complications: estimates and projections to the year 2010, Diab. Med.,14 (Suppl. 5),S81–85.

Arauz-Pacheco, C., Parrott, M.A., and Raskin, P., 2003, American Diabetes Association. Treatment of hypertension in adults with diabetes, Diabetes Care, 26, Suppl 1, S80-82

Bakris, G. L., Fonseca, V., and Katholi, R. E., 2004, Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial, JAMA, 292, 2227–2236.

Burt, V. L., Cutler, J. A., Higgins, M., Horan. M. J., Labarthe, D., and Whelton, P., 1995, Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the Health Examination Survey, 1960-1991, Hypertension,155,1855-1860.

Dahlof, B., Sever, P. S., and Poulter, N. R., 2005, Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial, Lancet,366, 895–906.

Douglas, J. G., Bakris, G. L., and Epstein, M., 2003, Management of high blood pressure in African Americans: consensus statement of the Hypertension in African AmericansWorking Group of the International Society on Hypertension in Blacks, Arch. Intern. Med.,163, 525–541.

Grossman, E., and Messerli, F.H., 1996, Diabetic and hypertensive heart disease, Ann Intern Med, 125, 304–310.

Grossman, E., Messerli, F. H., and Goldbourt, U., 2000, High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?, Arch. Intern. Med., 160, 2447–2452

Hyman, D. J., and Pavlik, V. N. , 2001, Characteristics of patients with uncontrolled hypertension in the United States, N. Eng. J. Med., 345, 479-486.

Klauser, R., Prager, R., and Gaube, S., 1991, Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus, Hypertension,17, 15–21.

Kjeldsen, S. E., Os, I., and Hoieggen, A.,2005, Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide, Am. J. Cardiovasc. Drugs, 5, 17–22.

Ministry of Health of Malaysia, 2002, Clinical practice guidelines on the management of hypertension 2002

Rosenbloom, A. L., Joe, J. R., Young, R. S., and Winter, W. E., 1999, Emerging epidemic of type 2diabetes in youth, Diabetes Care, 22, 345–354.

Schrier, R. W., Estacio, R. O., and Esler, A,, 2002, Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes, Kidney Int., 61,1086-1097.

UKPDS Study Group, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, Br. Med. J.,317,703–713.

Vijan, S., and Hayward, R. A., 2003, Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care, Ann. Intern. Med., 138, 593-602

Whelton, P. K., Barzilay, J., and Cushman, W. C., 2005, Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Arch. Intern. Med.,165,1401–1409.

World Health Organization,1999, International Society of Hypertension guidelines for the management of hypertension, J. Hypertens., 17,151-183.

Zimmet, P. Z., 1995, The pathogenesis and prevention of diabetes in adults: Genes, autoimmunity, and demography, Diabetes Care,18,1050-1064.



  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats